Yokohama-shi, Kanagawa | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 2	2026-10-05		NCT06979362
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack	Acute Myocardial Infarction (AMI); Cardiovascular Risk	Active, not recruiting	Phase 3	2026-09-09		NCT06118281
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)	Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease	Active, not recruiting	Phase 3	2026-09-04		NCT04822181
Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder	Enrolling by invitation	Not stated	2026-06-15		NCT06831734
A Study of Suizenji in Patients With Unresectable Pancreatic Cancer	Unresectable Pancreatic Cancer	Active, not recruiting	Not applicable	2026-03-16		NCT05601323
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 2	2026-03-11		NCT06979375